the effect of mexiletine , a new antiarrhythmic drug , was studied by oral ( 600 to 1200 mg/day ) or intravenous ( 250 mg in 10 minutes ) route in 45 patients ;
C0025887
mexiletine
C0003195
antiarrhythmic drug